INTRODUCTION
The hydrogel scleral explant (MIRAgel; MIRA Inc., Waltham, MA) was introduced in the late 1970s as a soft, pliable material for scleral buckling in retinal detachment repair. It is designed for expansion on hydration by tissue fl uids, thereby enlarging postoperatively. The implant was originally intended for epi-Ⅲ BACKGROUND AND OBJECTIVE: To report symptoms of extrusion of hydrogel explants after retinal detachment (RD) repair and the outcomes and complications following removal.
Ⅲ PATIENTS AND METHODS: All 23 patients had previous RD repair by episcleral buckle with hydrogel explant. Signs and symptoms of scleral buckle (SB) extrusion were analyzed. Main outcomes measured were redetachment of the retina, persistent diplopia, and decreased postoperative visual acuity (VA).
Ⅲ RESULTS: Mean time between RD repair and removal of extruded SB was 16.2 years (range: 11 to 21 years). Fifteen patients (65%) received encircling SB and 8 had segmental SB. SB was combined with vitrectomy in 12 patients and 3 received silicone oil. Common complaints included limited ocular motility, presence of a palpable mass under the eyelid, pain and discomfort, diplopia, visible SB under eroded conjunctiva, complete immobility, and signs of infection. Two eyes were phthisical. No scleral perforations occurred during removal of explants. After SB removal, RD recurred in 2 patients and diplopia persisted in 4. VA was not affected by SB removal.
Ⅲ CONCLUSION: Deterioration may occur after implantation for 10 years or longer. This is due to microstructural change of the hydrogel material. The most common problems are motility disturbance and presence of a tumor-like, palpable mass under the eyelid. Removal of the implant can alleviate some ocular problems. However, RD can recur and diplopia may persist after removal of the SB. Vision usually is not affected. scleral use as an adjunct to a more solid, intrascleral buckling device, but was then found suffi cient for use as the primary buckling material. Initial observations showed the hydrogel to be both effective and well tolerated. 1 More recently, however, multiple studies have been published that reveal several late complications of hydrogel scleral buckles, necessitating their removal. [2] [3] [4] [5] The complications result from buckle swelling due to hydrolytic degradation of the material. 4, 6 Common clinical indications for buckle removal include pain or discomfort, 2,7-10 external eye infl ammation, 2,7-10 presence of a palpable mass beneath the eyelid or conjunctiva 3, 5 (Figs. 1, 2 , and 3), exposed or migrating buckle elements, 2,3,6-9 sudden vision loss, 2 infection, 2,11 and diplopia or strabismus. 2, [5] [6] [7] [8] 10 Without knowledge of a patient's prior history, ophthalmologists may easily mistake an extruded scleral buckle for other pathology, such as orbital tumor.
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In this report, we present a series of 23 eyes of 23 patients who underwent removal of extruded hydrogel (MIRAgel) scleral buckles 11 to 21 years after placement (mean: 16.2 years). These patients presented with a variety of complaints, including the presence of a palpable mass under the eyelid, pain and discomfort, diplopia, visualization of the buckle eroding through the conjunctiva, loss of ocular motility, and signs of infection. We also examined the outcomes and complications following hydrogel buckle removal, such as redetachment of the retina and persistent diplopia.
PATIENTS AND METHODS
We reviewed the medical records of 23 consecutive patients who underwent removal of extruded hydrogel (MIRAgel) scleral buckles performed by a single surgeon (CJC) at the University of Mississippi Medical Center between 2005 and 2008. A total of 338 buckles were placed during the analyzed period. All of the patients had previous retinal detachment repair in the late 1980s and early 1990s by episcleral buckle with MIRAgel. All buckles were exoplants, secured using 5-0 polyester scleral sutures. No lamellar dissection was performed. There was no scleral pocket placement. Tenon's fascia was sutured separately from the conjunctiva using 8-0 polyglactin 910.
Of the 23 patients, 14 were male. Their ages ranged from 22 to 91 years, with a mean age of 58 years. There were 16 white, 6 African-American, and 1 Native American patients. Thirteen patients were pseudophakic (57%), 6 phakic (26%), and 4 aphakic (17%). The mean time between retinal detachment repair and removal of the extruded SB was 16.2 years, with a range of 11 to 21 years. Fifteen patients (65%) received en- circling and 8 received segmental scleral buckles. The scleral buckle placement was combined with vitrectomy in 12 patients (52%) and 3 (13%) received silicone oil at the time of the initial retinal detachment repair. The reasons for retinal detachment repair with scleral buckle placement included penetrating trauma (n = 5), blunt trauma (n = 3), regular rhegmatogenous retinal detachment (n = 10), retinal detachment with proliferative vitreoretinopathy (n = 6), and tractional retinal detachment (n = 2).
RESULTS
The symptoms and examination fi ndings on presentation with the extruded scleral buckles are summarized in Table 1 . The most common symptoms were the presence of a palpable mass under the eyelid (n = 11, 48%) and pain and discomfort (n = 8, 35%). Other symptoms included visualization of the buckle eroding through the conjunctiva (n = 6, 26%), diplopia (n = 7, 30%), complete immobility (n = 4, 17%), and signs of infection (n = 4, 17%).
Snellen visual acuity was 20/30 or better in 4 eyes (17%), 20/40 to 20/50 in 6 (26%), 20/60 to 20/80 in 3 (13%), 20/100 to 20/400 in 2 (8.7%), counting fi ngers in 3 (13%), hand motions in 1 (4.3%), light perception in 2 (8.7%), and no light perception in 1 (4.3%).
Ocular motility limitation was present in 16 eyes (70%). Ocular misalignment was present in 19 eyes (83%). Of those, 12 were exotropic (52%), 1 exophoric (4.3%), 3 esotropic (13%), 1 hypotropic (4.3%), and 2 hypertropic (8.7%).
Anterior segment fi ndings included corneal edema (n = 1, 4.3%), corneal opacifi cation or scarring (n = 5, 22%), iris defect (n = 1, 4.3%), episcleritis (n = 1, 4.3%), posterior synechiae (n = 1, 4.3%), and pupillary membrane (n = 1, 4.3%).
The retina was detached in 3 eyes (13%) and 2 eyes were phthisical (8.7%) on presentation with extruded scleral buckle.
Most buckles extruded into a single quadrant (n = 16, 70%). For single quadrant involvement, the inferotemporal quadrant was most common (n = 7, 30%), followed by superonasal (n = 5, 22%), inferonasal (n = 3, 13%), and superotemporal (n = 1, 4.0%). Five involved two quadrants (22%), one involved three quadrants (4%), and one buckle was extruded nearly 360 degrees (four quadrants). Overall, including the extrusions involving multiple quadrants, the inferotemporal quad- rant was involved most frequently (n = 12, 36%). The superonasal and inferonasal quadrants were involved equally (n = 8, 24%) and the superotemporal quadrant was involved least frequently (n = 5, 15%). The superotemporal quadrant most often had associated pain as a primary complaint (3 patients of 5 with superotemporal involvement, 60%). Motility limitation was seen most often with inferonasal extrusion (n = 7, 88%). Diplopia most often occurred with inferotemporal involvement (n = 4, 33%). Persistent diplopia after buckle removal was most common for inferonasal extrusion (n = 2, 25%). Table 2 summarizes these fi ndings. Table 3 Redetachment of the retina occurred in 2 of the 20 eyes in which the retina was attached prior to buckle removal. Four patients (of 7 who presented with diplopia) experienced diplopia that persisted even after buckle removal. None of the removals were complicated by intraoperative scleral perforation or postoperative infection. Pars plana vitrectomy or silicone oil injection performed at the time of buckle placement did not alter the likelihood of retinal redetachment or other observed complications.
DISCUSSION
Hydrogel episcleral buckles (MIRAgel) are commonly used for surgical retinal detachment repair. It has become known that deterioration of the hydrogel scleral explant implant may occur after implantation for 10 years or longer. This is due to microstructural changes of the material. Hydrolytic degradation of the hydrogel scleral explant has been confi rmed by the presence of carboxylic groups using micro-Fourier transform infrared spectroscopy. 4, 6 This change leads to water absorption, causing swelling and friability of the buckle, and manifesting clinically with the symptoms we have described here.
In the current series, the hydrogel scleral explant was invariably noted to be both swollen and friable at the time of buckle removal, fragmenting even with delicate instrument handling. It seems plausible, as suggested previously by Marin 4 and supported by RoldanPallares et al., 6 that some late insult may occur to the fi brous capsule surrounding the hydrogel implant, either by suture degradation or erosion or another mechanism, allowing water to access the material and resulting in excessive, late swelling and degradation. Areas of scleral thinning were also commonly noted. Removal of the hydrogel buckle was most effi ciently performed bluntly with a cotton-tipped applicator, minimizing fragmentation of the friable material with forceps and sharp instruments, and also decreasing the chance of scleral perforation.
It has been suggested previously that the more hydrogel material implanted into the eye, the greater the chance of eventually requiring removal. 4, 6 Our fi ndings give some support to this claim, with 15 of the 23 buckles removed being encircling bands (65%) and 8 of 23 smaller, segmental bands (35%).
It has also been suggested that traumatic etiology of retinal detachment (especially penetrating trauma), concurrent pars plana vitrectomy, and subsequent ocular procedures including cataract extraction, may increase the risk of subsequent scleral buckle removal. 12 In our series, 12 of the 23 patients did undergo concurrent pars plana vitrectomy at the time of buckle placement (52%), and 13 of 23 patients had cataract surgery before requiring removal of the buckle (57%), which lends some support to that claim. However, retinal detachment due to a traumatic mechanism was found in only 8 of 23 patients (35%). In our series, the most common type of retinal detachment was regular rhegmatogenous retinal detachment unrelated to trauma (43%).
The average time from hydrogel buckle placement to extrusion in our 23-patient series was 16.2 years. The most common problems were motility disturbance and the presence of a tumor-like, palpable mass under the eyelid, which could be mistaken for an orbital tumor or other pathology. The most common quadrant of extrusion was inferotemporal, probably due to gravity effect and being the area of least resistance. Diplopia occurred commonly with extrusion in this quadrant, maybe due to involvement of the inferior oblique and lateral and/or inferior rectus muscles.
Removal of the implant alleviated some ocular problems, such as pain and discomfort, presence of a palpable mass under the eyelid or eroding through the conjunctiva, signs of infection, and some cases of diplopia (3 of 7 resolved, 43%). However, retinal detachment recurred in 2 patients (of 20 who presented with attached retina at time of extrusion) and diplopia persisted in 4 (of 7 who presented with diplopia at time of extrusion) following scleral buckle removal. Visual acuity was not affected by removal. Based on our observations, long-term, annual follow-up is recommended for any patient with a hydrogel scleral explant (MIRAgel) as surveillance for symptoms of extrusion described here. Prompt removal may prevent progression of some complications. However, diplopia may persist following removal and redetachment of the retina may occur. Extruded hydrogel scleral explant should be considered in the differential diagnosis for orbital mass, especially when the full history is not known.
